BPG is committed to discovery and dissemination of knowledge
Articles in Press
12/17/2025 8:19:17 AM | Browse: 13 | Download: 0
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Minireviews |
| Article Title |
Ryanodine receptor 2 mutations in catecholaminergic polymorphic ventricular tachycardia: From molecular mechanisms to precision medicine
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Vaibhav Sharma |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Vaibhav Sharma, MD, Researcher, Internal Medicine, Medstar Washington Hospital Center, Washington, District of Columbia 20010, United States. vsharma3090@gmail.com |
| Key Words |
Ryanodine receptor 2 mutations; Catecholaminergic polymorphic ventricular tachycardia; Precision medicine; Calcium signaling; Genetic cardiology; Arrhythmia management; Sudden cardiac death |
| Core Tip |
Catecholaminergic Polymorphic Ventricular Tachycardia serves as a paradigm of precision cardiology, where a mechanistic unravelling of the ryanodine receptor 2-mediated Calcium ion channel abnormality helps in formulating a genotype-oriented treatment approach. Recent studies regarding the pathopharmacology of store overload-induced Calcium ion release, together with mitochondrial interactions, posit the possibility of a more complex pathophysiology than the classic electrical disorders. Recent milestones in the application of the CRISPR Gene editing tool, together with artificial intelligence-assisted diagnostic techniques in association with a personalized form of pharmacotherapy, have resulted in the successful treatment of 80 to 90% of the affected subjects. |
| Citation |
Sharma V. Ryanodine receptor 2 mutations in catecholaminergic polymorphic ventricular tachycardia: From molecular mechanisms to precision medicine. World J Cardiol 2025; In press |
 |
Received |
|
2025-06-23 10:44 |
 |
Peer-Review Started |
|
2025-06-23 10:44 |
 |
First Decision by Editorial Office Director |
|
2025-07-30 08:00 |
 |
Return for Revision |
|
2025-07-30 08:00 |
 |
Revised |
|
2025-08-01 06:11 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2025-12-17 02:42 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-12-17 08:19 |
 |
Articles in Press |
|
2025-12-17 08:19 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345